Emerging Therapy Solutions

What Emerging Therapy Solutions does

Emerging Therapy Solutions (ETS) is a Bloomington, Minnesota-based managed-services company that provides full management of cell and gene therapy (CGT) and transplant cases for payers, including self-insured employers, health plans, and stop-loss/reinsurance carriers. The company's core offering, the CGT360 platform, combines data-driven population analysis to identify members likely to require CGT with forecasting of anticipated therapy spend over multi-year horizons, factoring in both current and upcoming FDA approvals. ETS serves as the operational layer between payers and therapy delivery, handling patient identification, care navigation to therapy-specific Centers of Excellence (via its LifeTrac subsidiary network), prior authorization, medical policy support, and outcomes monitoring through to treatment conclusion. The company complements these services with value-based contracts negotiated with pharmaceutical manufacturers, which can refund a portion of claims if expected outcomes are not met, and risk pooling/transfer solutions delivered through financial management partners. ETS markets its services primarily via direct enterprise sales, supplemented by broker and consultant channels, and operates password-protected client portals (Knowledge Center, Referral and Contract) for case management and reporting. The company holds URAC Health Utilization Management accreditation (through 02/01/2029) and HITRUST r2 certification, supporting its credibility with risk-bearing payer clients. Founded in the early 1990s by David J. McLean and operated today as a private company with 11–50 employees, ETS has raised approximately $24.3 million across multiple exempt securities offerings between 2019 and 2024, with disclosed participation from Telegraph Hill Partners.

Name

Emerging Therapy Solutions

Legal name

Emerging Therapy Solutions, Inc.

Website

https://emergingtherapies.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Emerging Therapy Solutions is a Bloomington, Minnesota-based managed-services company that helps self-insured employers, health plans, and stop-loss carriers anticipate, navigate, and financially manage cell and gene therapy and transplant cases through its CGT360 platform and LifeTrac Center of Excellence network.

Ownership category

akta.pro rank

Product category

Healthcare utilization management

NAICS

All Other Outpatient Care Centers (621498), Social Assistance (624)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Gene Therapy Regulatory, Pharmacovigilance & Clinical Operations Services (HLAAACAM)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE), Transplantation & Advanced Therapies Pharmaceuticals (incl. Cell & Gene Therapies) (HLAIAAAO)

Keywords

• Cell and gene therapy management
• Transplant case management
• Payer risk management
• Specialty drug utilization management
• Centers of Excellence network

Headquarters

HQ city

Bloomington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. CGT Management Services: ETS provides comprehensive management services for cell and gene therapies and transplants to payers including self-insured employers, health plans, and stop-loss carriers. Revenue appears to be generated through contracted service fees, likely per-member-per-month or per-case basis for the risk management, care navigation, and outcomes monitoring services.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Emerging Therapy Solutions provides end-to-end management services for cell and gene therapies (CGT) and organ transplants to payer organizations, anchored by the CGT360 platform. Services include predictive population analytics to identify at-risk members, care navigation to qualified Centers of Excellence, prior authorization and medical policy support, value-based contracts with pharmaceutical manufacturers, and risk pooling/transfer solutions. The company also operates the LifeTrac Network of qualified providers and publishes specialized program guides for cell therapies, gene therapies, and transplant services.

Product overview

Emerging Therapy Solutions (ETS) operates as a unified platform company focused on cell and gene therapies (CGT) and transplant management. The core product is CGT360, a comprehensive solution encompassing data-driven population analysis for identifying at-risk members, care navigation to Centers of Excellence (COEs), and financial management including value-based contracts with manufacturers and risk transfer solutions. Supporting the platform are the ETS Knowledge Center Client Portal and ETS Referral and Contract Client Portal for registered users, the LifeTrac subsidiary network identifying qualified providers as Programs of Excellence and Experience, and specialized program guides for specific therapies (CAR-T, gene therapies, transplant). The company serves self-insured employers, health plans, and secondary payers with URAC-accredited utilization management.

Differentiator

Problem solved

Functional benefit

Products and services

• CGT360 A comprehensive, proactive total-coverage solution for cell and gene therapy (CGT) and transplant management. Combines data-driven population analysis to identify at-risk members, predictive spend forecasting, care navigation to therapy-specific Centers of Excellence, prior authorization and medical policy support, value-based contracts with manufacturers, and outcomes monitoring across the treatment journey.
• ETS Knowledge Center Client Portal Password-protected portal for registered users providing access to clinical content, therapeutic information, and educational resources related to cell and gene therapies.
• ETS Referral and Contract Client Portal Password-protected portal for registered users to manage referrals, single case agreements, and provider contracting for cell and gene therapy and transplant services.
• LifeTrac Network Subsidiary network of healthcare facilities delivering quality, cost-effective care for transplant and cell and gene therapy cases. Providers are designated as Programs of Excellence or Programs of Experience based on treatment experience, staffing, and outcomes.
• Cell Therapy Program Guides Specialized program guides covering CAR-T therapies and other cell therapies, helping payers identify and coordinate care at qualified Centers of Excellence.
• Gene Therapy Program Guides Comprehensive program guides covering gene therapies including Casgevy, Elevidys, Hemgenix, Lenmeldy, Luxturna, Lyfgenia, Zolgensma, and Zynteglo.
• Transplant Program Guides Program guides for adult and pediatric transplant services providing resources for managing complex transplant cases at qualified Centers of Excellence.

Quantifiable outcome

• Precise forecasting of anticipated spend over coming months and years
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Regional players

• RxBenefits: RxBenefits provides pharmacy benefit consulting and specialty drug management services to self-funded employer plans and brokers. Comparable in serving the self-insured employer segment with specialty drug management focus, though broader than CGT.

Emerging players

• AccessHope: AccessHope provides employer-sponsored cancer care navigation and expert medical opinions, partnering with self-insured employers. Comparable business model of serving self-insured employers with high-cost care navigation, though focused on oncology rather than CGT specifically.
• HSTechnology Solutions: HST offers utilization management, case management, and clinical review services for payers and managed care plans. Comparable in providing utilization management and clinical operations services to payer clients, though broader than CGT focus.
• InformedDNA: InformedDNA is a genetics services company providing genetic counseling, utilization management, and outcomes tracking for genetic and genomic medicine, including gene therapies. Comparable to ETS in the genetic/genomic utilization management niche for payers.

Direct peers

• CareMetx: CareMetx (formerly part of Sentry Data Systems) is a specialty hub services provider that helps patients access complex specialty therapies, including cell and gene therapies, working directly with payers and manufacturers. Highly comparable to ETS in serving high-cost therapy patient access and reimbursement.
• PharmaCord: PharmaCord is a patient access and support services company that partners with pharmaceutical manufacturers to deliver commercial services for specialty and gene therapies, including reimbursement, case management, and care coordination. Directly comparable to ETS in CGT-specific services for payers.

Broad incumbents

• CVS Health (Caremark/Specialty): CVS Caremark and CVS Specialty offer specialty pharmacy and utilization management for high-cost therapies. A broad incumbent that could either compete with or partner alongside ETS for CGT management.
• Evernorth Health Services: Evernorth is Cigna Group's health services portfolio including Express Scripts, Accredo specialty pharmacy, and MDLIVE. As a broad incumbent, it serves many of the same payer customers but with generalist capabilities rather than CGT-specialized focus.
• Optum Health: Optum is UnitedHealth Group's health services and innovation arm, providing utilization management, specialty pharmacy (Optum Specialty Pharmacy / OptumRx), and care navigation. A broad incumbent that competes for payer spend on specialty therapy management.
• eviCore (Evernorth): eviCore provides utilization management and prior authorization services for complex specialty treatments including oncology and gene therapy for health plans. Comparable in payer-facing utilization management for high-cost specialty care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/emergingtherapysolutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emerging Therapy Solutions